Global Amino Acid Metabolism Disorders Treatment Market

Amino Acid Metabolism Disorders Treatment Comprehensive Study by Application (Argininosuccinic acidemia, Citrullinemia, Homocystinuria, Maple syrup urine disease, Phenylketonuria, Tyrosinemia type I), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales), Treatment Type (Medicines, Supplements, Blood tests, Dialysis, Transplants) Players and Region - Global Market Outlook to 2026

Amino Acid Metabolism Disorders Treatment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
The study covers a detailed analysis segmented by key business segments i.e. , by application (Argininosuccinic acidemia, Citrullinemia, Homocystinuria, Maple syrup urine disease, Phenylketonuria and Tyrosinemia type I) and major geographies. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Amino Acid Metabolism Disorders Treatment market throughout the predicted period.

What is Amino Acid Metabolism Disorders Treatment?
Amino acid metabolism disorders are rare health situations that affect the metabolism of the body. Metabolism is that the way body changes food into the energy it must breathe, digest food and grow. Babies get confirmed for some of these disorders right after birth. These tests are called newborn screening. These conditions are inherited. Which means they’re passed from parent to child through genes. Genes are parts of the body's cells that store instructions for the way body grows and works. In the United States, all babies have newborn screening tests to see if they may have certain inherited conditions, like amino acid metabolism disorders. According to the National Organization for Rare Disorders, the incidence of PKU from newborn screening programs ranges from one in 13,500 to 19,000 newborns in the United States.

The competition is expected to become even more intense in the years to come due to entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Amino Acid Metabolism Disorders Treatment market analysis report suggests strategies Players can follow and recommends key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, including:
  • Pfizer (United States)
  • AMINO GmbH (Germany)
  • Merck KGaA (Germany)
  • GlaxoSmithKline PLC (United Kingdom)
  • Civentichem (United States)
  • Recordati S.p.A. (Italy)
  • Koninklijke DSM N.V. (Netherlands)
  • Kyowa Hakko Kirin Co., Ltd (Japan)
  • Sanofi (France)
  • Shine Star (Hubei) Biological Engineering Co. (China)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Market Trend
Advancements in Drug Delivery Technologies and On-Going Clinical Trials Regarding Amino Acid Metabolism Disorder Treatment
Restraints
  • Risk of Infections Associated With Repeated Injections

Opportunities
High Healthcare Expenditure and Raising Awareness about Metabolic Disease in Developing Countries and Growing Healthcare Infrastructure in the Developing Economies

Key highlights of the Global Amino Acid Metabolism Disorders Treatment market Study:
• CAGR of the market during the forecast period 2020-2026
• In-depth information on growth factors that will accelerate the Amino Acid Metabolism Disorders Treatment market in next few years.
• Detailed Insights on futuristic trends and changing consumer behaviour
• Forecast of the Global Amino Acid Metabolism Disorders Treatment market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Amino Acid Metabolism Disorders Treatment Players

Transformation and Important Trigegrs:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Amino Acid Metabolism Disorders Treatment market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Amino Acid Metabolism Disorders Treatment market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Metabolic Disease Treatment Drugs Manufacturers, Metabolic Disorders Drugs Suppliers, Medical Research Laboratories, Research and Development (R&D) Companies, Market Research and Consulting Service Providers and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Application
  • Argininosuccinic acidemia
  • Citrullinemia
  • Homocystinuria
  • Maple syrup urine disease
  • Phenylketonuria
  • Tyrosinemia type I
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

By Treatment Type
  • Medicines
  • Supplements
  • Blood tests
  • Dialysis
  • Transplants

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing incidences of Inherited Metabolic Diseases due to Changing Lifestyles
      • 3.2.2. Growing Prevalence of Hyperammonemia
    • 3.3. Market Challenges
      • 3.3.1. Increasing Cost of Amino Acid Supplements
    • 3.4. Market Trends
      • 3.4.1. Advancements in Drug Delivery Technologies
      • 3.4.2. On-Going Clinical Trials Regarding Amino Acid Metabolism Disorder Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Amino Acid Metabolism Disorders Treatment, by Application, Distribution Channel, Treatment Type and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Amino Acid Metabolism Disorders Treatment (Value)
      • 5.2.1. Global Amino Acid Metabolism Disorders Treatment by: Application (Value)
        • 5.2.1.1. Argininosuccinic acidemia
        • 5.2.1.2. Citrullinemia
        • 5.2.1.3. Homocystinuria
        • 5.2.1.4. Maple syrup urine disease
        • 5.2.1.5. Phenylketonuria
        • 5.2.1.6. Tyrosinemia type I
      • 5.2.2. Global Amino Acid Metabolism Disorders Treatment by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Online Sales
      • 5.2.3. Global Amino Acid Metabolism Disorders Treatment by: Treatment Type (Value)
        • 5.2.3.1. Medicines
        • 5.2.3.2. Supplements
        • 5.2.3.3. Blood tests
        • 5.2.3.4. Dialysis
        • 5.2.3.5. Transplants
      • 5.2.4. Global Amino Acid Metabolism Disorders Treatment Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Amino Acid Metabolism Disorders Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. AMINO GmbH (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck KGaA (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GlaxoSmithKline PLC (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Civentichem (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Recordati S.p.A. (Italy)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Koninklijke DSM N.V. (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Kyowa Hakko Kirin Co., Ltd (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sanofi (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Shine Star (Hubei) Biological Engineering Co. (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Amino Acid Metabolism Disorders Treatment Sale, by Application, Distribution Channel, Treatment Type and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Amino Acid Metabolism Disorders Treatment (Value)
      • 7.2.1. Global Amino Acid Metabolism Disorders Treatment by: Application (Value)
        • 7.2.1.1. Argininosuccinic acidemia
        • 7.2.1.2. Citrullinemia
        • 7.2.1.3. Homocystinuria
        • 7.2.1.4. Maple syrup urine disease
        • 7.2.1.5. Phenylketonuria
        • 7.2.1.6. Tyrosinemia type I
      • 7.2.2. Global Amino Acid Metabolism Disorders Treatment by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Online Sales
      • 7.2.3. Global Amino Acid Metabolism Disorders Treatment by: Treatment Type (Value)
        • 7.2.3.1. Medicines
        • 7.2.3.2. Supplements
        • 7.2.3.3. Blood tests
        • 7.2.3.4. Dialysis
        • 7.2.3.5. Transplants
      • 7.2.4. Global Amino Acid Metabolism Disorders Treatment Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Amino Acid Metabolism Disorders Treatment: by Application(USD Million)
  • Table 2. Amino Acid Metabolism Disorders Treatment Argininosuccinic acidemia , by Region USD Million (2015-2020)
  • Table 3. Amino Acid Metabolism Disorders Treatment Citrullinemia , by Region USD Million (2015-2020)
  • Table 4. Amino Acid Metabolism Disorders Treatment Homocystinuria , by Region USD Million (2015-2020)
  • Table 5. Amino Acid Metabolism Disorders Treatment Maple syrup urine disease , by Region USD Million (2015-2020)
  • Table 6. Amino Acid Metabolism Disorders Treatment Phenylketonuria , by Region USD Million (2015-2020)
  • Table 7. Amino Acid Metabolism Disorders Treatment Tyrosinemia type I , by Region USD Million (2015-2020)
  • Table 8. Amino Acid Metabolism Disorders Treatment: by Distribution Channel(USD Million)
  • Table 9. Amino Acid Metabolism Disorders Treatment Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 10. Amino Acid Metabolism Disorders Treatment Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 11. Amino Acid Metabolism Disorders Treatment Online Sales , by Region USD Million (2015-2020)
  • Table 12. Amino Acid Metabolism Disorders Treatment: by Treatment Type(USD Million)
  • Table 13. Amino Acid Metabolism Disorders Treatment Medicines , by Region USD Million (2015-2020)
  • Table 14. Amino Acid Metabolism Disorders Treatment Supplements , by Region USD Million (2015-2020)
  • Table 15. Amino Acid Metabolism Disorders Treatment Blood tests , by Region USD Million (2015-2020)
  • Table 16. Amino Acid Metabolism Disorders Treatment Dialysis , by Region USD Million (2015-2020)
  • Table 17. Amino Acid Metabolism Disorders Treatment Transplants , by Region USD Million (2015-2020)
  • Table 18. South America Amino Acid Metabolism Disorders Treatment, by Country USD Million (2015-2020)
  • Table 19. South America Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 20. South America Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 21. South America Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 22. Brazil Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 23. Brazil Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 24. Brazil Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 25. Argentina Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 26. Argentina Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 27. Argentina Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 28. Rest of South America Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 29. Rest of South America Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 30. Rest of South America Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 31. Asia Pacific Amino Acid Metabolism Disorders Treatment, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 33. Asia Pacific Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 34. Asia Pacific Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 35. China Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 36. China Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 37. China Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 38. Japan Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 39. Japan Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 40. Japan Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 41. India Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 42. India Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 43. India Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 44. South Korea Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 45. South Korea Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 46. South Korea Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 47. Taiwan Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 48. Taiwan Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 49. Taiwan Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 50. Australia Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 51. Australia Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 52. Australia Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 56. Europe Amino Acid Metabolism Disorders Treatment, by Country USD Million (2015-2020)
  • Table 57. Europe Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 58. Europe Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 59. Europe Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 60. Germany Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 61. Germany Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 62. Germany Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 63. France Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 64. France Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 65. France Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 66. Italy Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 67. Italy Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 68. Italy Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 69. United Kingdom Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 70. United Kingdom Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 71. United Kingdom Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 72. Netherlands Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 73. Netherlands Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 74. Netherlands Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 75. Rest of Europe Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 76. Rest of Europe Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 77. Rest of Europe Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 78. MEA Amino Acid Metabolism Disorders Treatment, by Country USD Million (2015-2020)
  • Table 79. MEA Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 80. MEA Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 81. MEA Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 82. Middle East Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 83. Middle East Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 84. Middle East Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 85. Africa Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 86. Africa Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 87. Africa Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 88. North America Amino Acid Metabolism Disorders Treatment, by Country USD Million (2015-2020)
  • Table 89. North America Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 90. North America Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 91. North America Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 92. United States Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 93. United States Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 94. United States Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 95. Canada Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 96. Canada Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 97. Canada Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 98. Mexico Amino Acid Metabolism Disorders Treatment, by Application USD Million (2015-2020)
  • Table 99. Mexico Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 100. Mexico Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2015-2020)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Amino Acid Metabolism Disorders Treatment: by Application(USD Million)
  • Table 112. Amino Acid Metabolism Disorders Treatment Argininosuccinic acidemia , by Region USD Million (2021-2026)
  • Table 113. Amino Acid Metabolism Disorders Treatment Citrullinemia , by Region USD Million (2021-2026)
  • Table 114. Amino Acid Metabolism Disorders Treatment Homocystinuria , by Region USD Million (2021-2026)
  • Table 115. Amino Acid Metabolism Disorders Treatment Maple syrup urine disease , by Region USD Million (2021-2026)
  • Table 116. Amino Acid Metabolism Disorders Treatment Phenylketonuria , by Region USD Million (2021-2026)
  • Table 117. Amino Acid Metabolism Disorders Treatment Tyrosinemia type I , by Region USD Million (2021-2026)
  • Table 118. Amino Acid Metabolism Disorders Treatment: by Distribution Channel(USD Million)
  • Table 119. Amino Acid Metabolism Disorders Treatment Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 120. Amino Acid Metabolism Disorders Treatment Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 121. Amino Acid Metabolism Disorders Treatment Online Sales , by Region USD Million (2021-2026)
  • Table 122. Amino Acid Metabolism Disorders Treatment: by Treatment Type(USD Million)
  • Table 123. Amino Acid Metabolism Disorders Treatment Medicines , by Region USD Million (2021-2026)
  • Table 124. Amino Acid Metabolism Disorders Treatment Supplements , by Region USD Million (2021-2026)
  • Table 125. Amino Acid Metabolism Disorders Treatment Blood tests , by Region USD Million (2021-2026)
  • Table 126. Amino Acid Metabolism Disorders Treatment Dialysis , by Region USD Million (2021-2026)
  • Table 127. Amino Acid Metabolism Disorders Treatment Transplants , by Region USD Million (2021-2026)
  • Table 128. South America Amino Acid Metabolism Disorders Treatment, by Country USD Million (2021-2026)
  • Table 129. South America Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 130. South America Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 131. South America Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 132. Brazil Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 133. Brazil Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 134. Brazil Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 135. Argentina Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 136. Argentina Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 137. Argentina Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 138. Rest of South America Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 139. Rest of South America Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 140. Rest of South America Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 141. Asia Pacific Amino Acid Metabolism Disorders Treatment, by Country USD Million (2021-2026)
  • Table 142. Asia Pacific Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 143. Asia Pacific Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 144. Asia Pacific Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 145. China Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 146. China Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 147. China Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 148. Japan Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 149. Japan Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 150. Japan Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 151. India Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 152. India Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 153. India Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 154. South Korea Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 155. South Korea Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 156. South Korea Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 157. Taiwan Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 158. Taiwan Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 159. Taiwan Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 160. Australia Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 161. Australia Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 162. Australia Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 163. Rest of Asia-Pacific Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 164. Rest of Asia-Pacific Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 165. Rest of Asia-Pacific Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 166. Europe Amino Acid Metabolism Disorders Treatment, by Country USD Million (2021-2026)
  • Table 167. Europe Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 168. Europe Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 169. Europe Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 170. Germany Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 171. Germany Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 172. Germany Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 173. France Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 174. France Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 175. France Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 176. Italy Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 177. Italy Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 178. Italy Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 179. United Kingdom Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 180. United Kingdom Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 181. United Kingdom Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 182. Netherlands Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 183. Netherlands Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 184. Netherlands Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 185. Rest of Europe Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 186. Rest of Europe Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 187. Rest of Europe Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 188. MEA Amino Acid Metabolism Disorders Treatment, by Country USD Million (2021-2026)
  • Table 189. MEA Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 190. MEA Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 191. MEA Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 192. Middle East Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 193. Middle East Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 194. Middle East Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 195. Africa Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 196. Africa Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 197. Africa Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 198. North America Amino Acid Metabolism Disorders Treatment, by Country USD Million (2021-2026)
  • Table 199. North America Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 200. North America Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 201. North America Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 202. United States Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 203. United States Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 204. United States Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 205. Canada Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 206. Canada Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 207. Canada Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 208. Mexico Amino Acid Metabolism Disorders Treatment, by Application USD Million (2021-2026)
  • Table 209. Mexico Amino Acid Metabolism Disorders Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 210. Mexico Amino Acid Metabolism Disorders Treatment, by Treatment Type USD Million (2021-2026)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Amino Acid Metabolism Disorders Treatment: by Application USD Million (2015-2020)
  • Figure 5. Global Amino Acid Metabolism Disorders Treatment: by Distribution Channel USD Million (2015-2020)
  • Figure 6. Global Amino Acid Metabolism Disorders Treatment: by Treatment Type USD Million (2015-2020)
  • Figure 7. South America Amino Acid Metabolism Disorders Treatment Share (%), by Country
  • Figure 8. Asia Pacific Amino Acid Metabolism Disorders Treatment Share (%), by Country
  • Figure 9. Europe Amino Acid Metabolism Disorders Treatment Share (%), by Country
  • Figure 10. MEA Amino Acid Metabolism Disorders Treatment Share (%), by Country
  • Figure 11. North America Amino Acid Metabolism Disorders Treatment Share (%), by Country
  • Figure 12. Global Amino Acid Metabolism Disorders Treatment share by Players 2020 (%)
  • Figure 13. Global Amino Acid Metabolism Disorders Treatment share by Players (Top 3) 2020(%)
  • Figure 14. Global Amino Acid Metabolism Disorders Treatment share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 17. Pfizer (United States) Revenue: by Geography 2020
  • Figure 18. AMINO GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 19. AMINO GmbH (Germany) Revenue: by Geography 2020
  • Figure 20. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Merck KGaA (Germany) Revenue: by Geography 2020
  • Figure 22. GlaxoSmithKline PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. GlaxoSmithKline PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 24. Civentichem (United States) Revenue, Net Income and Gross profit
  • Figure 25. Civentichem (United States) Revenue: by Geography 2020
  • Figure 26. Recordati S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 27. Recordati S.p.A. (Italy) Revenue: by Geography 2020
  • Figure 28. Koninklijke DSM N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 29. Koninklijke DSM N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 30. Kyowa Hakko Kirin Co., Ltd (Japan) Revenue, Net Income and Gross profit
  • Figure 31. Kyowa Hakko Kirin Co., Ltd (Japan) Revenue: by Geography 2020
  • Figure 32. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 33. Sanofi (France) Revenue: by Geography 2020
  • Figure 34. Shine Star (Hubei) Biological Engineering Co. (China) Revenue, Net Income and Gross profit
  • Figure 35. Shine Star (Hubei) Biological Engineering Co. (China) Revenue: by Geography 2020
  • Figure 36. Global Amino Acid Metabolism Disorders Treatment: by Application USD Million (2021-2026)
  • Figure 37. Global Amino Acid Metabolism Disorders Treatment: by Distribution Channel USD Million (2021-2026)
  • Figure 38. Global Amino Acid Metabolism Disorders Treatment: by Treatment Type USD Million (2021-2026)
  • Figure 39. South America Amino Acid Metabolism Disorders Treatment Share (%), by Country
  • Figure 40. Asia Pacific Amino Acid Metabolism Disorders Treatment Share (%), by Country
  • Figure 41. Europe Amino Acid Metabolism Disorders Treatment Share (%), by Country
  • Figure 42. MEA Amino Acid Metabolism Disorders Treatment Share (%), by Country
  • Figure 43. North America Amino Acid Metabolism Disorders Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Pfizer (United States)
  • AMINO GmbH (Germany)
  • Merck KGaA (Germany)
  • GlaxoSmithKline PLC (United Kingdom)
  • Civentichem (United States)
  • Recordati S.p.A. (Italy)
  • Koninklijke DSM N.V. (Netherlands)
  • Kyowa Hakko Kirin Co., Ltd (Japan)
  • Sanofi (France)
  • Shine Star (Hubei) Biological Engineering Co. (China)
Select User Access Type

Key Highlights of Report


Apr 2021 221 Pages 52 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Amino Acid Metabolism Disorders Treatment Market Quantitative research analysis
Global Amino Acid Metabolism Disorders Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Amino Acid Metabolism Disorders Treatment Market is heading robustly to achieve new growth cycle.
The Concentration Rate of Global Amino Acid Metabolism Disorders Treatment market is dominated by European Players to generate healthy valuation by 2026.
Companies that are profiled in Global Amino Acid Metabolism Disorders Treatment Market are Pfizer (United States), AMINO GmbH (Germany), Merck KGaA (Germany), GlaxoSmithKline PLC (United Kingdom), Civentichem (United States), Recordati S.p.A. (Italy), Koninklijke DSM N.V. (Netherlands), Kyowa Hakko Kirin Co., Ltd (Japan), Sanofi (France) and Shine Star (Hubei) Biological Engineering Co. (China) etc.

Know More About Global Amino Acid Metabolism Disorders Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Addictions Therapeutics Comprehensive Study by Type (Therapy, Medications and Treatment (Nalaxone, Naltrexone, Bupropion, Disulfiram, Nicotine replacement products, Methadone, Varenicline)), Applicat...
$ 3450
Hyperhidrosis Treatment Comprehensive Study by Type (Antiperspirants, Iontophoresis, Botulinum toxin injections, Prescription cloth wipes, Prescription medicine, Surgery), Application (Hospitals, Der...
$ 3650
Allergy Diagnostics And Treatment Comprehensive Study by Application (Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes, Other End Users), Tests Type (Specific IgE te...
$ 3750
Monoclonal Antibodies Drug Comprehensive Study by Application (Oncology, Autoimmune, Inflammatory Diseases, Respiratory Diseases, Ophthalmology, Others), Origin (Murine Antibodies, Human Antibodies, ...
$ 3650
Medical Skincare Comprehensive Study by Type (Cleansers, Toners, Scrubs & Masks, Serums, Moisturizers, Eye Creams, SPF, Others), Application (Acne, Anti-Aging, Brightening, Sensitive Skin, Dry Skin, ...
$ 3750
Weight Loss Therapeutics Comprehensive Study by Therapy (Intensive Behavioural Therapy, Self-Monitoring Therapy), End Users (Hospitals, Therapy Clinics, Pharmaceuticals Organization), Distribution Ch...
$ 3650